
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39289407
71321
10.1038/s41598-024-71321-6
Article
Prevalence of onychomycosis among psoriasis patients: a clinico-mycological and dermoscopic comparative cross sectional study
Abdo Hamed M. 1
Hassab-El-Naby Hussein M. 1
Bashtar Mohamed R. 1
Hasan Mohamed S. 1
http://orcid.org/0000-0001-7541-5241
Elsaie Mohamed L. Egydoc77@yahoo.com

2
1 https://ror.org/05fnp1145 grid.411303.4 0000 0001 2155 6022 Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
2 https://ror.org/02n85j827 grid.419725.c 0000 0001 2151 8157 Department of Dermatology, Venereology and Andrology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt
18 9 2024
18 9 2024
2024
14 217436 5 2024
27 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Onychomycosis, a nail infection caused by dermatophytes, yeast, and molds makes up roughly half of all onychopathies and is the most prevalent nail condition in the world. Clinically, nail psoriasis and onychomycosis can frequently be difficult to distinguish from one another. To assess the prevalence of onychomycosis in patients with psoriasis. Fifty patients with psoriasis associated with nail disease were included in this study. After taking clinical history, nail samples were gathered for dermoscopic inspection, culture, direct microscopy with 20% KOH solution, and nail clipping with PAS stain. Of the 50 patients recruited, 43 were males and 7 were females, with mean age 6–71 years (mean ± SD 44.06 ± 16.2). Eleven patients (22%) tested positive for onychomycosis. Dermatophytes were isolated from 2% of patients, yeast from 14% of patients, and non-dermatophytic mold from 38% of patients. Histopathological results revealed fungal hyphae and spores in 18% of patients. The most prevalent dermoscopic sign in psoriatic patients with onychomycosis was spikes (81.8%) with statistical significance (P-value < 0.001), while nail pitting was the most prevalent dermoscopic feature in nail psoriasis. This study lays the way for an accurate diagnosis of nail lesions by highlighting the significance of cooperation between mycology, histology, and dermoscopy in the diagnosis of onychomycosis in patients with nail psoriasis.

Keywords

Psoriasis
Oychomycosis
Mycology
Dermoscopy
Histopathology
Subject terms

Diseases
Health care
Medical research
National Research Centre EgyptOpen access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Psoriasis is characterized clinically by skin lesions and extracutaneous comorbidities side by side to systemic inflammation1. Erythematous, indurated, and scaling plaques with discomfort, itching, and a burning feeling are typical cutaneous signs of psoriasis2.

A fungal infection of the nail unit, specifically the nail bed, known as onychomycosis results in gradual changes to the nail's color, texture, and structure. Regardless of the cause, it is an invasive nail fungal infection3. It has an insidious onset and if left untreated, progresses until it involves the entire nail plate. Onychomycosis rarely resolves spontaneously, nor does it respond to placebo therapy taken orally or applied topically3.

Onychomycosis is more common in people with nail psoriasis4. According to studies, immunosuppressive medications and/or structural changes in nail psoriasis may be the main causes5,6. Onychomycosis was not considerably more common in psoriatic patients, according to some experts. The rapid growth of the affected nails in psoriasis may inhibit the development of onychomycosis due to the quick turnover and elimination of the distal nail plate, possibly decreasing the opportunity for fungi to invade the nail keratin7. This is one explanation for why psoriasis may increase nail protection against fungal invasion8–10. Additionally, the serum like glycoprotein substance that was discovered in psoriatic oil drop patches may possibly have an inhibitory effect on dermatophytes11. This study included mycological, histopathological, and dermoscopical examinations to assess the prevalence of onychomycosis in psoriasis patients.

Patients and methods

Fifty psoriatic patients (diagnosed clinically or pathologically) associated with finger nail disease were included in this study. Participants were recruited from the outpatient clinic of the Dermatology and Venerology department at Al-Azhar University Hospital in Cairo, Egypt. The study was approved by the Faculty of Medicine Al-Azhar University's Research Ethics Committee (00012367-21-02-002). All participants or their guardians gave their informed consent to participate in the trial. All patients of the study were subjected to detailed history-taking including personal history, history of the present illness, past history, and family history of psoriasis. Patients who received any topical or systemic antifungals during the previous 3 months or were suffering from any disease-causing nail dystrophy such as eczema and lichen planus were excluded.

Mycological examination

The suspected nails were cleaned with 70% alcohol to remove contaminants. Scrapings were taken with a sterile scalpel blade and collected in a sterile clean container. The friable subungual debris was collected as well as the scraping of the nail bed. The collected specimens were divided into three portions. The first portion of the specimens was examined microscopically using 20% potassium hydroxide (KOH). The second and third portions were cultured on Sabouraud dextrose agar, one with and another without cycloheximide.

Histopathological examination

After collection of the specimens for mycological testing, a nail clipping is taken and put in a plane tube. With the help of a nipper, a fragment of at least 5 mm longitudinally and 2 mm transversely of the affected nails was cut for an adequate fragment fixation in paraffin. The extracted specimen was placed in a formaldehyde solution. When processing this specimen, a chitin-softening or Tween solution may be used. Periodic acid Schiff (PAS) stain for the demonstration of fungal hyphae was used in the current study.

Onychoscopy

All affected nails were examined by a handheld dermatoscopy (DermliteDL4N; 4 Gen, Inc, San Juan Capistrano, CA), with a magnification of 10×. Higher magnification of up to 30× was used wherever deemed necessary. Images were recorded directly by a device Samsung Note 10 Plus attached to the dermoscopy. Both non-polarized and polarized modes were used. Non-polarized and dry mode helps in the detection of nail plate changes, whereas polarized mode with or without fluid is best for nail bed changes.

Based on clinical, mycology, histopathology and dermoscopy results (CMHD), we have postulated that presence of a clinical picture including (subungual hyperkeratosis, onycholysis, nail discoloration) as well fungal elements in histopathology with dermatophytes in culture as well as key dermoscopic features of (spikes, ruin appearance, white lunula and aurora patterns) to be a definite diagnosis of onychomycosis.

Results

The age of the patients ranged from 6 to 71 years, with a mean of 44.06 ± 16.2, including 7 (14%) females and 43 (86%) males. The time of diagnosis of psoriatic disease ranged from 1 to 40 years previously among patients with a mean of 11.2 ± 7.9 years. Table 1 Regarding the manifestations, the most common type of psoriasis was plaque psoriasis (n = 27; 54%), and all patients were on topical treatments and the most common systemic treatment used was methotrexate.Table 1 Demographic data in all studied patients.

Data	Studied patients
(N = 50)	
Age (years)	Mean ± SD	44.06 ± 16.2	
Min–Max	6–71	
Sex	Male	43	86%	
Female	7	14%	
Occupation	Manual worker	21	42%	
Non-manual worker	29	58%	
Risk factors	Smoking	12	24%	
Sun exposure	34	68%	
Family history	Negative	39	78%	
Positive	11	22%	
Co-morbidities	Psoriatic arthritis	18	36%	
HTN	6	12%	
DM	6	12%	
Residence	Rural	33	66%	
Urban	17	34%	
DM: diabetes mellitus; HTN: hypertension.

Mycological analyses showed among the 50 patients, the rate of onychomycosis to be 22% (11 patients). The least frequent fungi were from the dermatophyte group (one patient, 2%), and identified as T. Violaceum. Yeasts were identified in seven cases (14%), and all occurred on the fingernails but three simultaneously on fingernails and toenails. C. parapsilosis was the most frequent species (five patients, 10%). There was growth of nondermatophyte fungi in nineteen (38%) of culture of which Aspergillus and Penicillium species were the commonest (Tables 2, 3, 4; Figs. 1, 2).Table 2 Isolated fungi.

Isolated fungi	Studied group N = 50	
Dermatophytes; No. = 1 (2%)	
 Trichophyton violaceum	1	2%	
Yeasts; No. = 7 (14%)	
 Candida parapsilosis	5	10%	
 Trichosporon species	2	4%	
Non-dermatophytic molds; No. = 19 (38%)	
Single growth No. = 11 (22%)	
 Aspergillus species	3	6%	
 Penicillium species	2	4%	
 Unknown molds	2	4%	
 Alternaria species	1	2%	
 Cladosporium species	1	2%	
 Phialophora species	1	2%	
 Fonsecaea species	1	2%	
Mixed growth; No. = 8 (16%)	
 Mold + mold; No. = 6 (12%)	6	12%	
 Mold + yeast; No. = 2(4%)	2	4%	
Histopathology results	
 Positive	9	18%	
 Negative	41	82%	

Table 3 Correlation between diagnosis of onychomycosis and dermoscopic results in all studied patients.

	Diagnosis	X2	P-value	
Psoriasis without onychomycosis
(N = 39)	Psoriasis with onychomycosis
(N = 11)	
Dermoscopy	Pitting	35	89.7%	6	54.5%	7.2	0.007 S	
Splinter hemorrhage	18	46.2%	5	45.4%	0.001	0.967 NS	
Ruin pattern	0	0%	7	63.6%	28.8	 < 0.001 HS	
Onycholysis	31	79.4%	5	45.5%	4.9	0.026 S	
Subungual hyperkeratosis	12	30.8%	7	63.6%	3.9	0.047 S	
Spikes	0	0.0%	9	81.8%	38.9	 < 0.001 HS	
Salmon patch	18	46.2%	5	45.4%	0.001	0.967 NS	
Longitudinal striation	2	5.1%	4	36.4%	7.9	0.005 S	
Transverse striations	7	17.9%	6	54.5%	5.9	0.015 S	
Nail thickening	0	0%	6	54.5%	24.1	 < 0.001 HS	
Oil drop	0	0%	0	0%	–	–	
Aurora borealis	0	0%	0	0%	–	–	
χ2: chi-square test; S significant; HS: highly significant; NS: non-significant.

Table 4 Correlation between diagnosis and clinical findings in all studied patients.

	Diagnosis	X2	P-value	
Psoriasis with no onychomycosis
(N = 39)	Psoriasis with onychomycosis
(N = 11)	
Clinical Findings	Subungual hyperkeratosis	12	30.8%	7	63.6%	3.9	0.047 S	
Onycholysis	31	79.5%	6	54.5%	2.77	0.095 NS	
Nail discoloration (yellow)	8	20.5%	10	90.9%	18.5	 < 0.001S	
Pitting	35	89.7%	5	45.5%	10.5	0.001 S	
Splinter hemorrhage	10	25.6%	2	18.2%	0.26	0.608 NS	
Oil drop	0	0%	0	0%	–	–	
Leukonychia	5	12.8%	0	0%	1.56	0.210 NS	
Paronychia	1	2.6%	0	0%	0.28	0.591 NS	
χ2: chi-square test; S: significant; HS: highly significant; NS: non-significant.

Significant values are in bold.

Fig. 1 (A) clinical photo shows: DLSO. (B) dermoscopy photo shows: 1 = subungual hyperkeratosis, 2 = salmon patch, 3 = structureless area (onycholysis), 4 = pitting. (C) mycology culture shows trichosporon species, (D) KOH examination shows trichosporon species, and (E) histopathology photo shows: fungal spores.

Fig 2. (A) clinical photo shows: DLSO. (B) dermoscopy photo shows: 1 = spikes, 2 = subungual hyperkeratosis, 3 = salmon patch. (C) mycology culture shows Candida species. (D) Histopathology photo shows: 4 = fungal spores.

Regarding dermoscopic signs in nail psoriasis without onychomycosis (Table 3), we found that pitting was the most prevalent feature (89.7%). The second most common dermoscopic finding in nail psoriasis was onycholysis (79.4%). Spikes were significantly the most common finding occurring in 9 out of 11 cases (81.8%) (P-value < 0.001) when compared to psoriatic cases without onychomycosis. This was followed by the ruin pattern in 7 cases (63.6%).

The histopathological analysis showed 9 (18%) positive samples for fungi and three (7.9%) showed typical histological alterations of psoriasis. but this does not allow the identification of the fungal species present. regarding dermoscopic signs in psoriatic patients with onychomycosis, spikes were the most significant common finding in 9 out of the 11 (81.8%) patients (P-value < 0.001) (Tables 2, 3, 4).

Discussion

Psoriasis is a common chronic inflammatory skin disease that affects approximately 2% of the population in the Western world12. Onychomycosis is a fungal infection of the nail plate caused by dermatophytes, yeast, and molds. Onychomycosis is the most common nail disease worldwide and constitutes about half of all onychopathies. Both psoriasis and onychomycosis are common diseases in the general population13.

In the current study, the patient’s age ranged from 6 to 71 years; with a mean age of (44.06 ± 16.2) that matched other studies showing mid forties to be an average mean age for seeking medical advice in general population14,15. Male patients were 43 (86%) and female patients were 7 patients (14%) and the duration of psoriasis ranged between 1 and 40 years with mean of 11.2 ± 7.9 years.

Concerning the associated diseases, 6 patients had hypertension (12%), 6 patients had diabetes (12%) while 18 (36%) suffered from psoriatic arthritis. Similar to our results, several studies found that diabetes mellitus and hypertension are more prevalent in psoriasis patients16–18. Aalemi et al., Chiu et al., Duan et al.17–19. The current study found that 11 patients (22%) had a family history of psoriasis. A higher incidence was reported by Solmaz et al.19 who found that 31.9% of their patients had a family history of psoriasis or psoriatic arthritis while Augustin et al.20 found positive family history in 11% of patients with nail psoriasis.

In the current study, eleven out of the 50 psoriatic patients (22%) were diagnosed as having onychomycosis. Histopathological diagnosis was conclusive in nine cases (18%) while mycological cultures demonstrated dermatophyte in one patient and dermoscopic criteria of onychomycosis (ruin pattern and spikes) were present in sixteen patients. A lower prevalence of onychomycosis in patients with nail psoriasis was found by Klaassen et al.21, Gupta et al.22, and Al-Mutairi et al.23, who found a prevalence of 18%, 10.22%, and 20.3% respectively. On the other hand, a higher prevalence was observed by Tabassum et al.24, Tsentemeidou et al.25, Rigopoulos et al.8 who reported the frequency of onychomycosis among patients to be 34%. Other authors (Jendoubi et al.26 and Alves et al.27), reported onychomycosis prevalence among psoriatic patients to be 53% and 57.89% respectively. The highest incidence (62%) was reported by Zisova et al.28 in a military population. The discrepancy in the results of the different studies could be explained by the use of different diagnostic parameters. Obviously, the correlation between mycological, histopathological, and dermoscopic tools as practiced in this study will largely exclude false-positive and false-negative results.

Trichophyton violaceum was the only isolated dermatophyte from one patient (2%) in the current study. This was relatively less than the results of Romaszkiewicz et al.29, and Tabassum et al.24 who isolated dermatophytes in 7% and 6.6% respectively. Alves et al.27 isolated dermatophytes in 23.6% mostly from toenails in Brazil among which half of them belonged to T. rubrum. Generally, mycoses are endemic in countries of South America, especially in rural communities which could explain the increased incidence of onychomycosis in the later study.

Non-dermatophytic molds and yeasts were isolated from 19 (38%) and 7 patients (14%) respectively; of which were identified as Candida and Trichosporon species. Romaszkiewicz et al.29, isolated Candida species from 10 patients (9.8%) and Geotrichum species from 2 patients (1.96%). Yeasts were isolated with a higher percentage in the studies of Kacar et al.30, Tabassum et al.24, Alves et al.27, and Romaszkiewicz et al.29 where the incidence was 23%, 36%, 43%, and 50% respectively. A lower incidence of non-dermatophytic mold isolation was reported by Tabassum et al.24, in 36%, and Kacar et al.30 in 15%. On the other hand, Alves et al.24 reported no isolation of non dermatophyte filamentous fungi. Earlier conclusions identified nails of psoriasis patients are at a higher risk of colonization; as altered subungual tissue and onycholysis could facilitate yeast invasion31.

The difference in fungal isolation rates could be related to the varied demographic characteristics of the patients enrolled in the studies. Also, different methods of fungal identification and interpretation between different studies could be a factor. Moreover; the role of immunosuppressive medications in inhibiting non dermatophytes and possibly facilitating proliferation of dermatophytes and yeasts can also be considered when interpreting such findings31. Another aspect is the possibility that the use of nail clippings collects samples only from the distal portion of the nail, reducing positivity rates due to the absence of live fungal structures in the distal portion. Increased positivity could be achieved by collecting material from the proximal portion of the nails32.

On PAS-stained histopathological nail clippings, fungal hyphae and spores were found in 9 patients (18%) that matched results of Abu El-Hamd et al.33 In the current study, the positive histopathological result of fungal elements was considered to be diagnostic of onychomycosis. Yet, still, many researchers depend on mycological cultures and dermoscopic signs because it is easier and less aggressive.

Dermoscopic examination in cases diagnosed with onychomycosis found that spikes were significantly the most common finding occurring in 9 out of 11 cases (81.8%) (P-value < 0.001) when compared to psoriatic cases without onychomycosis. This was followed by the ruin pattern in 7 cases (63.6%) which was in accordance with Ankad et al.34 who observed spikes and ruin pattern in 90% and 65% respectively.

Regarding dermoscopic signs in nail psoriasis without onychomycosis (Table 3), we found that pitting was the most prevalent feature (89.7%). Similar results were reported by other studies35–40. The highest incidence of pitting (92.5%) was reported by Polat and Kapıcıoğlu41. The second most common dermoscopic finding in nail psoriasis was onycholysis (79.4%). Different studies reported onycholysis to be the most common clinical sign of nail psoriasis36,42,43. On the other hand, a study by Yorulmaz et al.44, found splinter hemorrhage (73.1%) to be the most common clinical finding in nail psoriasis.

The study had some limitations, such as the sample number, which was relatively small to allow broader conclusions. In conclusion; the present study establishes the way for an accurate diagnosis of nail lesions by highlighting the significance of utilizing mycology, histology, and dermoscopy in the diagnosis of onychomycosis in patients with nail psoriasis. Further investigations are needed, including longitudinal and randomised studies to obtain further evidence on the relationship between onychomycosis and psoriatic disease.

Author contributions

All authors (H.A, H.H, M.B, M.H and M.E) contributed equally in the production of this work. H.A, H.H, M.B, M.H and M.E designed and performed the research. H.A, H.H, M.B, M.H and M.E performed the work; H.A, H.H, M.B, M.H and M.E analyzed and wrote the paper.

Funding

Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).

Data availability

"The data that support the findings of this study are available from the corresponding author upon reasonable request."

Competing interests

The authors declare no competing interests.

Study approval

This study protocol was reviewed and approved by ethics committee on human research by Al Azhar faculty of medicine (IRB 00012367-00-00-025). All methods were performed in accordance with the relevant guidelines and regulations.

Consent to participate

Written informed consents were received from participants upon explanation of the study. Consent for publication was obtained from the participants for publishing the images in the manuscript.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Gudjonsson JE Karason A Runarsdottir EH Antonsdottir AA Hauksson VB Jonsson HH Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients—an analysis of 1019 HLA-C- and HLA-B-typed patients J. Investig. Dermatol. 2006 126 4 740 745 16439971
Gudjonsson, J. E. et al. Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients—an analysis of 1019 HLA-C- and HLA-B-typed patients. J. Investig. Dermatol. 126(4), 740–745 (2006).16439971
2. Reich K Approach to managing patients with nail psoriasis J. Eur. Acad. Dermatol. Venereol. 2009 23 15 21 19686381
Reich, K. Approach to managing patients with nail psoriasis. J. Eur. Acad. Dermatol. Venereol. 23, 15–21 (2009).19686381
3. Ghannoum M Azole resistance in dermatophytes: Prevalence and mechanism of action J. Am. Pediatr. Med. Assoc. 2016 106 79 86
Ghannoum, M. Azole resistance in dermatophytes: Prevalence and mechanism of action. J. Am. Pediatr. Med. Assoc. 106, 79–86 (2016).
4. Lipner SR Scher RK Onychomycosis: Clinical overview and diagnosis J. Am. Acad. Dermatol 2019 80 835 851 29959961
Lipner, S. R. & Scher, R. K. Onychomycosis: Clinical overview and diagnosis. J. Am. Acad. Dermatol 80, 835–851 (2019).29959961
5. Zaitz, C., Campbell, I., Marques, S. A., Ruiz, L. R. B. & Framil, V. M. S. Compˆendio de MicologiaM´edica, GuanabaraKoogan, Rio de Janeiro, Brazil, 23–25 (2010).
6. Yadav P Singal A Pandhi D Das S Clinico-mycological study of dermatophyte toenail onychomycosis in New Delhi, India Indian J. Dermatol. 2015 60 2 153 25814703
Yadav, P., Singal, A., Pandhi, D. & Das, S. Clinico-mycological study of dermatophyte toenail onychomycosis in New Delhi, India. Indian J. Dermatol. 60(2), 153 (2015).25814703
7. Carney, C. K., Cantrell, W. & Elewski, B. E. Nail psoriasis: A review of current topical and systemic therapiesx. Adv. Psoriasis Inflamm. Skin Dis. 1(3) (2010).‏
8. Rigopoulos D Papanagiotou V Daniel R III Piraccini BM Onychomycosis in patients with nail psoriasis: A point-to-point discussion Mycoses. 2017 60 1 6 10 27523738
Rigopoulos, D., Papanagiotou, V., Daniel, R. III. & Piraccini, B. M. Onychomycosis in patients with nail psoriasis: A point-to-point discussion. Mycoses. 60(1), 6–10 (2017).27523738
9. Rizzo D Alaimo R Tilotta G Dinotta F Bongiorno MR Incidence of onychomycosis among psoriatic patients with nail involvement: A descriptive study Mycoses 2013 56 498 499 23368934
Rizzo, D., Alaimo, R., Tilotta, G., Dinotta, F. & Bongiorno, M. R. Incidence of onychomycosis among psoriatic patients with nail involvement: A descriptive study. Mycoses 56, 498–499 (2013).23368934
10. Sánchez-Regaña M Llambí-Mateos F Salleras-Redonnet M Sancho MI Totosaus HC Umbert-Millet P Compounding as a current therapeutic option in dermatology Actas Dermo-Sifiliográficas (English Edition). 2013 104 9 738 756
Sánchez-Regaña, M. et al. Compounding as a current therapeutic option in dermatology. Actas Dermo-Sifiliográficas (English Edition). 104(9), 738–756 (2013).
11. Neofytos, D. Ketoconazole. In Kucers’ The Use of Antibiotics, 2731–2755 (CRC Press, 2017).
12. Nada HA Elshabrawy MM Elenain SAA Elsaie ML Implications of narrowband ultraviolet B treatment on psoriasis severity and serum levels of angiopoietin-2: A cross-sectional controlled study J. Cosmet. Dermatol. 2022 21 1 392 395 34496134
Nada, H. A., Elshabrawy, M. M., Elenain, S. A. A. & Elsaie, M. L. Implications of narrowband ultraviolet B treatment on psoriasis severity and serum levels of angiopoietin-2: A cross-sectional controlled study. J. Cosmet. Dermatol. 21(1), 392–395 (2022).34496134
13. Kardjeva V Summerbell R Kantardjiev T Devliotou-Panagiotidou D Sotiriou E Graser Y Forty-eight-hour diagnosis of onychomycosis with subtyping of Trichophyton rubrum strains J. Clin. Microbiol. 2006 44 4 1419 1427 16597871
Kardjeva, V. et al. Forty-eight-hour diagnosis of onychomycosis with subtyping of Trichophyton rubrum strains. J. Clin. Microbiol. 44(4), 1419–1427 (2006).16597871
14. Bozdemir NY Yuksel EI Toraman ZA Cicek D Demir B Gunbey F Factors affecting onychomycosis in patients with psoriasis Dermatol. Ther. 2022 35 7 e15513 35426221
Bozdemir, N. Y. et al. Factors affecting onychomycosis in patients with psoriasis. Dermatol. Ther. 35(7), e15513 (2022).35426221
15. Natarajan V Nath AK Thappa DM Singh R Verma SK Coexistence of onychomycosis in psoriatic nails: A descriptive study Indian J. Dermatol. Venereol. Leprol. 2010 76 6 723 724 21079333
Natarajan, V., Nath, A. K., Thappa, D. M., Singh, R. & Verma, S. K. Coexistence of onychomycosis in psoriatic nails: A descriptive study. Indian J. Dermatol. Venereol. Leprol. 76(6), 723–724 (2010).21079333
16. Aalemi AK Hamdard AG Chen H Association of metabolic syndrome with pediatric psoriasis: A case-control study in Kabul, Afghanistan Int. J. Dermatol. 2020 59 4 451 456 32043572
Aalemi, A. K., Hamdard, A. G. & Chen, H. Association of metabolic syndrome with pediatric psoriasis: A case-control study in Kabul, Afghanistan. Int. J. Dermatol. 59(4), 451–456 (2020).32043572
17. Chiu HY Hung CJ Muo CH Fan KC Sung FC The bidirectional association between type 2 diabetes and psoriasis: Two retrospective cohort studies Indian J. Dermatol. Venereol. Leprol. 2020 209 211
Chiu, H. Y., Hung, C. J., Muo, C. H., Fan, K. C. & Sung, F. C. The bidirectional association between type 2 diabetes and psoriasis: Two retrospective cohort studies. Indian J. Dermatol. Venereol. Leprol. 209, 211 (2020).
18. Duan X Liu J Mu Y Liu T Chen Y Yu R Xiong X Wu T A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates Medicine 2020 99 9 e19303 32118749
Duan, X. et al. A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates. Medicine 99(9), e19303 (2020).32118749
19. Solmaz D Bakirci S Kimyon G Gunal EK Dogru A Bayindir O Dalkilic E Ozisler C Can M Akar S Cetin GY Impact of having family history of psoriasis or psoriatic arthritis on psoriatic disease Arthritis Care Res. 2020 72 1 63 68
Solmaz, D. et al. Impact of having family history of psoriasis or psoriatic arthritis on psoriatic disease. Arthritis Care Res. 72(1), 63–68 (2020).
20. Augustin M Reich K Blome C Schafer I Laass A Radtke MA Nail psoriasis in Germany. Epidemiology and burden of disease Br. J. Dermatol. 2010 163 580 585 20456340
Augustin, M. et al. Nail psoriasis in Germany. Epidemiology and burden of disease. Br. J. Dermatol. 163, 580–585 (2010).20456340
21. Klaassen KM Dulak MG van de Kerkhof PC Pasch MC The prevalence of onychomycosis in psoriatic patients: A systematic review J. Eur. Acad. Dermatol. Venereol. 2014 28 5 533 541 24033871
Klaassen, K. M., Dulak, M. G., van de Kerkhof, P. C. & Pasch, M. C. The prevalence of onychomycosis in psoriatic patients: A systematic review. J. Eur. Acad. Dermatol. Venereol. 28(5), 533–541 (2014).24033871
22. Gupta AK Daigle D Foley KA The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations J. Eur. Acad. Dermatol. Venereol. 2015 29 1039 1044 25413984
Gupta, A. K., Daigle, D. & Foley, K. A. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations. J. Eur. Acad. Dermatol. Venereol. 29, 1039–1044 (2015).25413984
23. Al-Mutairi N Nour T Al-Rqobah D Onychomycosis in patients of nail psoriasis on biologic therapy. A randomized, prospective open label study comparing etanercept, infliximab and adalimumab Biol. Ther. 2013 13 5 625 629
Al-Mutairi, N., Nour, T. & Al-Rqobah, D. Onychomycosis in patients of nail psoriasis on biologic therapy. A randomized, prospective open label study comparing etanercept, infliximab and adalimumab. Biol. Ther. 13(5), 625–629 (2013).
24. Tabassum S Rahman A Awan S Jabeen K Farooqi J Ahmed B Kapadia N Factors associated with onychomycosis in nail psoriasis: A multicenter study in Pakistan Int. J. Dermatol. 2019 58 6 672 678 30615189
Tabassum, S. et al. Factors associated with onychomycosis in nail psoriasis: A multicenter study in Pakistan. Int. J. Dermatol. 58(6), 672–678 (2019).30615189
25. Tsentemeidou A Vyzantiadis TA Kyriakou A Sotiriadis D Patsatsi A Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study Mycoses. 2017 60 12 830 835 28877373
Tsentemeidou, A., Vyzantiadis, T. A., Kyriakou, A., Sotiriadis, D. & Patsatsi, A. Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study. Mycoses. 60(12), 830–835 (2017).28877373
26. Jendoubi F Ben Lagha I Rabhi F Doss N Mrabet A Jaber K Dhaoui MR Nail involvement in psoriatic patients and association with onychomycosis: Results from a cross-sectional study performed in a military hospital in Tunisia Skin Appendage Disord. 2019 5 5 299 303 31559254
Jendoubi, F. et al. Nail involvement in psoriatic patients and association with onychomycosis: Results from a cross-sectional study performed in a military hospital in Tunisia. Skin Appendage Disord. 5(5), 299–303 (2019).31559254
27. Alves N Moreira TA Malvino LDS Rodrigues JJ Ranza R de Araújo LB Pedroso RDS Onychomycosis in psoriatic patients with nail disorders: Aetiological agents and immunosuppressive therapy Dermatol. Res. Pract. 2020 2020 7209518 32411192
Alves, N. et al. Onychomycosis in psoriatic patients with nail disorders: Aetiological agents and immunosuppressive therapy. Dermatol. Res. Pract. 2020, 7209518 (2020).32411192
28. Zisova L Valtchev V Sotiriou E Gospodinov D Mateev G Onychomycosis in patients with psoriasis. A multicentre study Mycoses 2012 55 2 143 147 21771106
Zisova, L., Valtchev, V., Sotiriou, E., Gospodinov, D. & Mateev, G. Onychomycosis in patients with psoriasis. A multicentre study. Mycoses 55(2), 143–147 (2012).21771106
29. Romaszkiewicz A Bykowska B Zabłotna M Sobjanek M Sławinska M Nowicki RJ The prevalence and etiological factors of onychomycosis in psoriatic patients Postepy Dermatol. Alergol. 2018 35 309 313 30008651
Romaszkiewicz, A. et al. The prevalence and etiological factors of onychomycosis in psoriatic patients. Postepy Dermatol. Alergol. 35, 309–313 (2018).30008651
30. Kacar N Ergin S Ergin C Erdogan BS Kaleli I The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: A prospective controlled trial Clin. Exp. Dermatol. 2007 32 1 1 5 16824053
Kacar, N., Ergin, S., Ergin, C., Erdogan, B. S. & Kaleli, I. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: A prospective controlled trial. Clin. Exp. Dermatol. 32(1), 1–5 (2007).16824053
31. Hassaan ZRAA Mohamed HAK Eldahshan RM Elsaie ML Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis Sci. Rep. 2023 13 1 19037 37923859
Hassaan, Z. R. A. A., Mohamed, H. A. K., Eldahshan, R. M. & Elsaie, M. L. Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis. Sci. Rep. 13(1), 19037 (2023).37923859
32. Vazheva GZ Zisova LG Becheva EA Chonov VR Dichev VD Miteva-Katrandzhieva TM Rachkovska ZV Orbetzova MM Belovezhdov VT In search of dermatophytes—frequency and etiology of fungal infections in patients with and without diabetes mellitus Folia Med. 2022 64 6 922 931
Vazheva, G. Z. et al. In search of dermatophytes—frequency and etiology of fungal infections in patients with and without diabetes mellitus. Folia Med. 64(6), 922–931 (2022).
33. Abu El-Hamd M Yassin FE-ZSE-D El-hamid NHA El-Sharkawy REED Clinical, dermoscopic, and histopathological evaluations of patients with nail disorders J. Cosmet. Dermatol. 2022 21 347 357 34806290
Abu El-Hamd, M., Yassin, F.E.-Z.S.E.-D., El-hamid, N. H. A. & El-Sharkawy, R. E. E. D. Clinical, dermoscopic, and histopathological evaluations of patients with nail disorders. J. Cosmet. Dermatol. 21, 347–357 (2022).34806290
34. Ankad BS Gupta A Alekhya R Saipriya M Dermoscopy of onycholysis due to nail psoriasis, onychomycosis and trauma: A cross sectional study in skin of color Indian Dermatol. Online J. 2020 11 777 783 33235845
Ankad, B. S., Gupta, A., Alekhya, R. & Saipriya, M. Dermoscopy of onycholysis due to nail psoriasis, onychomycosis and trauma: A cross sectional study in skin of color. Indian Dermatol. Online J. 11, 777–783 (2020).33235845
35. Rich P Griffiths CE Reich K Nestle FO Scher RK Li S Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year J. Am. Acad. Dermatol. 2008 58 2 224 231 18083272
Rich, P. et al. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J. Am. Acad. Dermatol. 58(2), 224–231 (2008).18083272
36. Brazzelli V Carugno A Alborghetti A Grasso V Cananzi R Fornara L De Silvestri A Borroni G Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience J. Eur. Acad. Dermatol. Venereol. 2012 26 1354 1359 21973119
Brazzelli, V. et al. Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience. J. Eur. Acad. Dermatol. Venereol. 26, 1354–1359 (2012).21973119
37. Palmou N Marzo-Ortega H Ash Z Goodfield M Coates LC Helliwell PS Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritis Dermatology 2012 223 4 370 373
Palmou, N. et al. Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritis. Dermatology 223(4), 370–373 (2012).
38. Choi JW Kim BR Seo E Youn SW Identification of nail features associated with psoriasis severity J. Dermatol. 2017 44 2 147 153 27599783
Choi, J. W., Kim, B. R., Seo, E. & Youn, S. W. Identification of nail features associated with psoriasis severity. J. Dermatol. 44(2), 147–153 (2017).27599783
39. Marina EM Botar-Jid C Bolboaca SD Roman II Senila CS Mihu CM Patterns of clinical nail appearances in patients with cutaneous psoriasis Clujul Med. 2017 90 1 22 27 28246493
Marina, E. M. et al. Patterns of clinical nail appearances in patients with cutaneous psoriasis. Clujul Med. 90(1), 22–27 (2017).28246493
40. Tanaka AA Werner B Farris C Tornesy C Microscopic examination of nail clippings from patients with palmoplantar pustulosis Dermatopathology 2019 6 4 213 219 31828062
Tanaka, A. A., Werner, B., Farris, C. & Tornesy, C. Microscopic examination of nail clippings from patients with palmoplantar pustulosis. Dermatopathology 6(4), 213–219 (2019).31828062
41. Polat A Kapıcıoğlu Y Dermoscopic findings of psoriatic nail and their relationship with disease severity Turk. Arch. Dermatol. Venerol. Turkderm. 2017 51 4 119 123
Polat, A. & Kapıcıoğlu, Y. Dermoscopic findings of psoriatic nail and their relationship with disease severity. Turk. Arch. Dermatol. Venerol. Turkderm. 51(4), 119–123 (2017).
42. Gisondi P Idolazzi L Girolomoni G Ultrasonography reveals nail thickening in patients with chronic plaque psoriasis Arch Dermatol. Res. 2012 304 9 727 732 23011659
Gisondi, P., Idolazzi, L. & Girolomoni, G. Ultrasonography reveals nail thickening in patients with chronic plaque psoriasis. Arch Dermatol. Res. 304(9), 727–732 (2012).23011659
43. Garbers LE Slongo H Fabricio LH Schmitt JV Bonalumi AF Incidence, clinical manifestations and clipping of nail psoriasis in the dermatology center of the Hospital Universitario Evangelico de Curitiba A Bras. Dermatol. 2016 91 3 300 305
Garbers, L. E., Slongo, H., Fabricio, L. H., Schmitt, J. V. & Bonalumi, A. F. Incidence, clinical manifestations and clipping of nail psoriasis in the dermatology center of the Hospital Universitario Evangelico de Curitiba. A Bras. Dermatol. 91(3), 300–305 (2016).
44. Yorulmaz A Artuz F A study of dermoscopic features of nail psoriasis Postepy Dermatol. Alergol. 2017 34 1 28 35 28286468
Yorulmaz, A. & Artuz, F. A study of dermoscopic features of nail psoriasis. Postepy Dermatol. Alergol. 34(1), 28–35 (2017).28286468
